申请人:Deng Yongqi
公开号:US20130096084A1
公开(公告)日:2013-04-18
The present invention provides a compound of the Formula I: (Formular I should be inserted here) or a pharmaceutically acceptable salt, solvate or ester thereof, wherein R, R1, R2 and R3 are as defined herein. The compounds are ERK inhibitors. Also disclosed are pharmaceutical compositions comprising the above compounds and methods of treating cancer using the same.
本发明提供了一种公式I的化合物:(应在此处插入公式I),或其药学上可接受的盐、溶剂或酯,其中R、R1、R2和R3如本文所定义。这些化合物是ERK抑制剂。还公开了包含上述化合物的药物组合物以及使用其治疗癌症的方法。